Glycopyrrolate
NDC 65219-801, Glycopyrrolate, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-801
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209328
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE.2 mg/mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-801-01 | 65219080101 | 25 VIAL, SINGLE-DOSE in 1 CARTON (65219-801-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-801-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/250eeef7-b1a9-45e7-a927-7807232e10beMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65219-801NADAC price for package 65219080101
GET /v1/drugs/nadac/65219080101
Use it
Look up 65219-801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.